Memphis, Tenn.-based, private equity-backed One GI selected ChronWell for its GI focus, technology capabilities and financial stability, according to a release.
“Adding ChronWell’s services to the One GI platform significantly enhances our ability to serve our patients and deliver value,” said Robbie Allen, One GI’s CEO. “ChronWell provides us with the tools we need to extend digital therapeutics.”
